Grants Program - CURE Epilepsy
Forecasted
Grants Program - CURE Epilepsy supports early-career and established investigators, funding innovative epilepsy studies and rare-epilepsy research tools to advance disease-modifying breakthroughs and cures.
Browse similar grants
Funder: CURE Epilepsy
Due Dates (Anticipated): January 2027 (Taking Flight LOI) | February 2027 (Rare Epilepsy partner registration) | March 2027 (Taking Flight full proposal) | June 2027 (Rare Epilepsy researcher LOI) | September 2027 (Rare Epilepsy full application)
Funding Amounts: Taking Flight: up to $125,000 over 18 months | Rare Epilepsy Partnership: up to $100,000 over one year
Summary: Supports novel epilepsy research and rare-epilepsy research tools to advance cures with “no seizures, no side-effects.”
Key Information: Researchers must submit a Letter of Intent before an invited full proposal; unsolicited proposals are not accepted.
Description
CURE Epilepsy funds investigator-initiated research aimed at disease-modifying breakthroughs and cures for epilepsy. Its Board of Directors, Scientific Advisory Council, and Research Team set the research vision, with annual priorities guided by promising trends and breakthrough potential. The program emphasizes innovative, risky, paradigm-shifting research rather than incremental advances.
The Taking Flight Award helps early-career investigators establish an independent research focus and generate data for future NIH or similar funding applications. It supports basic or clinical studies, but not clinical trials, and favors collaboration and multidisciplinary approaches. The Rare Epilepsy Partnership Award supports tools, techniques, model systems, and data collection platforms that accelerate rare-epilepsy research. These awards are co-funded with advocacy groups and must address the specific rare epilepsies represented by participating partners.
